Piramal Pharma Ltd announced that the board of the company has approved the issuance of shares for an amount not exceeding ₹10.50 bln by way of a rights issue to the eligible equity shareholders of the company as on the record date, via an exchange filing.
The shares of the company traded 10.33 % lower at 88.25 rupees on NSE at 12:12 PM.
